We are proud to bring the first treatment the SMA community who inspire us every day. Biogen is deeply committed to helping improve the lives of people with SMA and we work closely with the SMA patient community with the goal of understanding and incorporating the perspectives of patients and families into the decisions we make. SPINRAZATM (nusinersen) is now approved by Health Canada and Biogen will continue to work towards ensuring timely access for Canadians with SMA.

Once you have been prescribed with SPINRAZA, your physician can refer you to the SMA 360°Canada Program, where you will have access to a Family Access Manager (FAM). Your FAM will help guide you through the process and coordinate all aspects of treatment with SPINRAZATM , including:

  • Insurance and financial support
  • Drug logistics
  • Travel assistance
  • Product education